BIIB
Biogen Inc.
$138.98
-$1.69(-1.20%)
76
Overall
80
Value
72
Tech
--
Quality
Market Cap
$20.89B
Volume
642.19K
52W Range
$110.04 - $199.99
Target Price
$170.24
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $10.5B | $11.1B | $11.9B | $12.9B | $13.7B | $12.7B | $11.0B | $10.2B | $9.8B | $9.7B | ||
| Total Revenue | $10.8B | $11.4B | $12.3B | $13.5B | $14.4B | $13.4B | $11.0B | $10.2B | $9.8B | $9.7B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $1.2B | $1.5B | $1.6B | $1.8B | $2.0B | $1.8B | $2.1B | $2.3B | $2.5B | $2.3B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $9.5B | $10.0B | $10.6B | $11.6B | $12.4B | $11.6B | $8.9B | $7.9B | $7.3B | $7.4B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $4.5B | $-4.3B | $-5.1B | $-5.6B | $-5.4B | $-7.2B | $5.2B | $5.0B | $5.0B | $4.4B | ||
| Research & Development | $2.0B | $2.0B | $-2.3B | $-2.6B | $2.3B | $-4.0B | $2.5B | $2.2B | $2.5B | $2.0B | ||
| Research Expense | -- | -- | -- | -- | -- | -- | $2.5B | $2.2B | $2.5B | $2.0B | ||
| Selling, General & Administrative | $2.1B | $-1.9B | $1.9B | $2.1B | $2.4B | $2.5B | $2.7B | $2.4B | $2.5B | $2.4B | ||
| Selling & Marketing Expenses | -- | -- | -- | -- | -- | -- | $98.7M | $54.1M | $71.4M | $66.8M | ||
| General & Administrative Expenses | -- | -- | -- | -- | -- | -- | $2.7B | $2.4B | $2.5B | $2.4B | ||
| Promotion & Advertising | -- | -- | -- | -- | -- | -- | $98.7M | -- | -- | -- | ||
| Salaries & Wages | -- | -- | -- | -- | -- | -- | $-46.7M | -- | -- | -- | ||
| Depreciation & Amortization | $382.6M | $385.6M | $-814.7M | $-747.3M | $-489.9M | $-464.8M | $235.3M | $272.4M | $254.2M | $286.7M | ||
| Depreciation & Amortization | $382.6M | $385.6M | $-814.7M | $-747.3M | $-489.9M | $-464.8M | $235.3M | -- | -- | -- | ||
| Amortization | $382.6M | $385.6M | $-814.7M | $-747.3M | $-489.9M | $-464.8M | $5.8B | $5.7B | $8.4B | $9.7B | ||
| Other Operating Expenses | -- | $-10.2M | $-112.3M | $-185.0M | $-241.6M | $-232.9M | $-4.2M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $5.0B | $5.7B | $5.5B | $6.0B | $7.0B | $4.4B | $4.6B | $3.3B | $2.3B | $2.9B | ||
| EBITDA | $5.4B | $5.6B | $6.2B | $6.9B | $7.5B | $5.7B | $2.9B | $4.1B | $1.8B | $2.8B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $95.5M | $260.0M | $250.8M | $200.6M | $187.4M | $222.5M | $253.6M | -- | -- | -- | ||
| Intinc | $22.1M | $63.4M | $78.5M | $112.5M | $120.0M | $42.0M | $11.0M | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-73.4M | $-196.6M | $-172.3M | $-88.1M | $-67.4M | $-180.5M | $-278.9M | $157.3M | $7.9M | $-185.9M | ||
| Gain on Sale of Securities | $-36.5M | $-3.8M | $-30.0M | $109.6M | $197.7M | $675.0M | $824.9M | -- | -- | -- | ||
| Other Income/Expense | $174.2M | $524.8M | $228.3M | $13.1M | $-157.6M | $-781.7M | $1.0B | $847.2M | $315.5M | $282.7M | ||
| Other Special Charges | $-123.7M | $-217.4M | $-217.0M | $11.0M | $83.3M | $497.4M | $-1.1B | $108.2M | $-315.5M | $-255.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $93.4M | $33.1M | $900.0K | $12.0M | $1.5M | -- | -- | $131.1M | $218.8M | $30.2M | ||
| Special Income Charges | $-123.9M | $-502.7M | $-183.6M | $-112.2M | $6.9M | $103.8M | -- | $-131.1M | $-218.8M | $-30.2M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $4.8B | $4.9B | $5.1B | $5.9B | $7.1B | $5.3B | $2.0B | $3.6B | $1.3B | $1.9B | ||
| Pre-Tax Income | $4.8B | $4.9B | $5.1B | $5.9B | $7.1B | $5.0B | $1.7B | $3.6B | $1.3B | $1.9B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $1.2B | $1.2B | $2.5B | $1.4B | $1.2B | $992.3M | $52.5M | $632.8M | $135.3M | $273.8M | ||
| NET INCOME | ||||||||||||
| Net Income | $3.5B | $3.7B | $2.5B | $4.4B | $5.9B | $4.0B | $1.6B | $3.0B | $1.2B | $1.6B | ||
| Net Income (Continuing Operations) | $3.5B | $3.7B | $2.5B | $4.4B | $5.9B | $4.0B | $1.6B | $3.0B | $1.2B | $1.6B | ||
| Net Income (Discontinued Operations) | $3.5B | $3.7B | $2.5B | $4.4B | $5.9B | $4.0B | $1.6B | $3.0B | $1.2B | $1.6B | ||
| Net Income (Common Stockholders) | $3.5B | $3.7B | $2.5B | $4.4B | $5.9B | $4.0B | $1.6B | $3.0B | $1.2B | $1.6B | ||
| Normalized Income | $3.2B | $3.7B | $3.3B | $4.7B | $5.6B | $4.0B | -- | -- | -- | -- | ||
| TOTALS | ||||||||||||
| Total Expenses | $5.7B | $5.8B | $5.9B | $6.6B | $6.6B | $8.4B | $7.3B | $7.3B | $7.5B | $6.8B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $230.7M | $218.4M | $212.6M | $204.9M | $187.1M | $160.9M | $149.1M | $145.3M | $144.7M | $145.6M | ||
| Average Shares Outstanding (Diluted) | $231.2M | $218.8M | $213.0M | $205.3M | $187.4M | $161.3M | $149.6M | $146.0M | $145.6M | $145.9M | ||
| Shares Outstanding | $218.7M | $216.0M | $211.6M | $196.7M | $174.1M | $152.3M | $147.0M | $144.5M | $145.4M | $146.4M | ||
| Basic EPS | $15.38 | $16.96 | $11.94 | $21.63 | $31.47 | $24.86 | $10.44 | $20.96 | $8.02 | $11.21 | ||
| Basic EPS (Continuing Operations) | $15.38 | $16.96 | $11.94 | $21.63 | $31.47 | $24.86 | $10.44 | $20.96 | $8.02 | $11.21 | ||
| Diluted EPS | $15.34 | $16.93 | $11.92 | $21.58 | $31.42 | $24.8 | $10.4 | $20.87 | $7.97 | $11.18 | ||
| Diluted EPS (Continuing Operations) | $15.34 | $16.93 | $11.92 | $21.58 | $31.42 | $24.8 | $10.4 | $20.87 | $7.97 | $11.18 | ||
| OTHER METRICS | ||||||||||||
| Earnings from equity interest | -- | -- | -- | -- | -- | -- | $34.9M | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | -- | -- | -- | -- | $34.9M | -- | -- | -- | ||
| Gain On Sale Of Business | -- | -- | -- | -- | $-55.3M | $92.5M | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | -- | -- | -- | -- | -- | $503.7M | -- | -- | ||
| Interest Expense Operating | -- | -- | -- | -- | -- | -- | $-280.8M | -- | -- | -- | ||
| Minority Interests | $-46.2M | $7.1M | $-131.0M | $-43.3M | -- | $-59.9M | $-171.5M | $85.3M | $-400.0K | -- | ||
| Net Income From Other Gains Losses | -- | -- | -- | -- | -- | -- | $-34.9M | -- | -- | -- | ||
| Other Gand A | -- | -- | -- | -- | -- | -- | $2.7B | $2.4B | $2.5B | $2.4B | ||
| Othspecchg | -- | $-454.8M | $-120.0M | $-112.5M | -- | $-75.0M | -- | -- | -- | -- | ||
| Restruct | $93.4M | $33.1M | $900.0K | $12.0M | $1.5M | -- | -- | $131.1M | $218.8M | $30.2M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BIIB | $138.98 | -1.2% | 642.19K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |